Injectable Drug Delivery Market Dynamics, Growth Prospect and Consumption Analysis till 2024
The global Injectable Drug Delivery Market was appreciated at US$ 331.0 billion in 2015 and will touch the value of US$ 931.1 billion by the completion of the year 2024.
The most important reasons accountable for the
development of this market are the growing usage of biologics, growth in the
occurrence of long-lasting sicknesses, growing incidence of needle stick
wounds, and the paybacks of inoculations such as suitability, simplicity of
use, and abridged pain. These features have amplified the demand for the
devices for example auto injectors, safety syringes, and prefilled syringes.
Request a Sample Copy
of Injectable Drug Delivery Market Report @ https://www.millioninsights.com/industry-reports/injectable-drug-delivery-market/request-sample
Similarly, some more factors responsible for the growth of the global injectable drug delivery market are growing expenses on healthcare, better patient devotion to injectable drug delivery systems, growing demand for self-injection devices, technical progressions in injectable drug delivery devices, growing number of cancer and diabetes cases.
Injectable
Drug Delivery by Type Outlook (Revenue, USD Million, 2013 - 2024)
•
Devices
• Self- injection devices
• Conventional injection devices
•
Formulation
• Conventional Drug Delivery
• Novel Drug Delivery
• Others
Injectable
Drug Delivery Therapeutic Use Outlook (Revenue, USD Million, 2013 - 2024)
•
Autoimmune disorders
•
Hormonal disorders
•
Oncology
• Others
Injectable
Drug Delivery Devices End-User Application Outlook (Revenue, USD Million, 2013
- 2024)
•
Hospitals
•
Homecare Settings
• Others
Some of the important companies for injectable drug delivery market are Terumo Corporation, Schott AG, Baxter International, Eli Lilly and Company, Gerresheimer AG, Becton, Dickinson and Company, and Pfizer.
Access Injectable Drug
Delivery Market Report with TOC @ https://www.millioninsights.com/industry-reports/injectable-drug-delivery-market
By Region the global injectable drug delivery
industry can be classified as North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America will be the most important
region during the approaching years owing to greater occurrence of diabetes and
cancer cases, in addition to greater patient obedience for injectable drug
delivery devices. Asia-Pacific is the speedily developing region in the global
market. The most important causes for the speedy development within the region
are growing expenditure on healthcare, huge base of population and refining
structure of healthcare. Furthermore, the market is speedily increasing owing
to the huge uncharted market and growing alertness regarding the injectable
drug delivery systems in developing nations like China and India in the
Asia-Pacific region.
Comments
Post a Comment